Rilonacept (arcalyst) 220MG/VIL INJ
Ended Awarded Last action
- Contract number
- 36C26022F0237
- Awardee
-
Kiniksa Pharmaceuticals (Uk), LTD. UEI HBHWNLNMHSV5
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $195,452
Award facts
- Contract value 100% obligated
- $195,451.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Great Britain, United Kingdom
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $389 | |
| Original award | $195,063 |
About this award
This is a federal contract award to Kiniksa Pharmaceuticals (UK), LTD., a foreign-owned, for-profit biopharmaceutical company, to supply Rilonacept (Arcalyst) 220mg/vial injections. The contract, valued at $195,451.52, was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) under a General Services Administration (GSA) Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract. The contract has a ceiling value of $195,451.52 and a performance period through May 31, 2023. The contract does not have a set-aside designation. Kiniksa Pharmaceuticals (UK), LTD. is the prime contractor, and no subcontractors are identified. This contract supports the VA's healthcare programs, primarily the VA's Veterans Integrated Service Networks (VISNs) 12, 20, and 21, as well as the Federal Medical Center Carswell, a Bureau of Prisons facility. Arcalyst is used to treat recurrent pericarditis and cryopyrin-associated periodic syndromes.
Quick answers
Who was awarded contract 36C26022F0237?
36C26022F0237 was awarded to Kiniksa Pharmaceuticals (Uk), LTD. by Veterans Integrated Service Network 20 (Veterans Health Administration) on April 6, 2022.
How much is contract 36C26022F0237 worth?
The government has obligated $195,452 on 36C26022F0237.
Is contract 36C26022F0237 an order under another contract?
Yes. 36C26022F0237 is a delivery order under 36F79722D0002, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26022F0237 competed?
The extent of competition for 36C26022F0237 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award